Victory Capital Management Inc Humanigen, Inc Transaction History

Victory Capital Management Inc

  • $95.7 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022
SELL
$1.81 - $3.97 $32,817 - $71,980
-18,131 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$3.66 - $8.22 $58,256 - $130,837
-15,917 Reduced 46.75%
18,131 $67,000
Q3 2021

Nov 02, 2021
BUY
$5.93 - $17.83 $110,636 - $332,654
18,657 Added 121.22%
34,048 $202,000
Q2 2021

Aug 03, 2021
BUY
$13.54 - $22.74 $208,394 - $349,991
15,391 New
15,391 $267,000

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email